Targeted siRNA delivery to tumor cells by folate-PEG-appended dendrimer/glucuronylglucosyl-β-cyclodextrin conjugate
- 21 August 2018
- journal article
- research article
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 93 (1-2) , 41-52
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation MedicineMolecular Therapy Nucleic Acids, 2017
- Recent progress in development of siRNA delivery vehicles for cancer therapyAdvanced Drug Delivery Reviews, 2016
- Delivery strategies and potential targets for siRNA in major cancer typesAdvanced Drug Delivery Reviews, 2016
- RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?Annual Review of Pharmacology and Toxicology, 2016
- 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeuticsNano Today, 2015
- Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer CellsJournal of Medicinal Chemistry, 2015
- Chitosan nanoparticles for siRNA delivery: Optimizing formulation to increase stability and efficiencyJournal of Controlled Release, 2014
- Chitosan and its derivatives as nanocarriers for siRNA deliveryJournal of Drug Delivery Science and Technology, 2012
- Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systemsProceedings of the National Academy of Sciences, 2001
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998